Senate Democrats have reintroduced sweeping legislation to federally legalize marijuana, drawing a sharp contrast with the Trump administration’s current approach to cannabis reform. The Cannabis Administration and Opportunity Act, spearheaded by Senators Chuck Schumer, Cory Booker, and Ron Wyden, would completely remove marijuana from the federal Controlled Substances Act. This push for full descheduling arrives just after the DEA concluded a hearing on the Trump administration’s more incremental proposal to merely reclassify marijuana from Schedule I to Schedule III. While advocates view the administration’s reclassification effort as a positive nod to medical reality, they argue it falls short by keeping cannabis federally criminalized. Meanwhile, House Republicans are pulling in the opposite direction, actively advancing legislation to block the Trump administration’s rescheduling efforts altogether.
Rather than just tweaking marijuana’s legal category, the Democratic bill represents a comprehensive overhaul of federal drug policy with a heavy emphasis on restorative justice. The legislation would automatically expunge federal records for low-level marijuana convictions within a year of enactment. To fund community reinvestment, it imposes a federal excise tax starting at five percent for small businesses and scaling up to twenty-five percent for large corporations. This revenue would bankroll a new Cannabis Justice Office within the Justice Department, designed to provide job training, legal aid, and reentry services for communities disproportionately harmed by the War on Drugs.
On the regulatory side, the bill shifts oversight to a newly created Center for Cannabis Products within the FDA, working alongside the ATF and the Alcohol and Tobacco Tax and Trade Bureau. It also directly addresses the financial and operational hurdles of the current industry by directing federal authorities to open up banking access for legitimate cannabis businesses and establishing explicit protections to prevent the impending recriminalization of hemp-derived THC products. Individual states would still retain the right to prohibit the sale and production of marijuana within their borders, but they would be explicitly barred from blocking the transport of legal cannabis passing through their jurisdictions.
The legislation also introduces significant protections for federal workers and veterans. It bans most federal employment drug testing for marijuana, protects government security clearances from being revoked over cannabis use, and finally allows VA doctors to officially recommend medical marijuana to veterans. To address public health and safety concerns, the bill mandates a ban on flavored vaping products, caps retail sales at ten ounces per transaction, and requires the Department of Transportation to develop a scientific standard for THC-impaired driving. For advocacy groups, the bill represents the only real path forward, arguing that merely rescheduling marijuana risks corporate monopolization while leaving the damaging legal architecture of the War on Drugs fully intact.
Dabbin-Dad Newsroom
